Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels | Haematologica
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis | HTML
Immunofixation - an overview | ScienceDirect Topics
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents | SpringerLink
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
Cureus | Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report
IgA-producing lymphoplasmacytic lymphoma carrying the chromosomal abnormality t(8;14)
Light chain myeloma: A brief report from India Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D - Indian J Pathol Microbiol
Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis. - Abstract - Europe PMC
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Multiple Myeloma | SpringerLink
Biomedicines | Free Full-Text | The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma | Leukemia
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma | Haematologica
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses | Mucosal Immunology
Inter-patient heterogeneity in Multiple Myeloma. The two main... | Download Scientific Diagram
Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain - ScienceDirect
Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation - ScienceDirect
Frontiers | Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse
Multiple Myeloma: Diagnosis and Treatment | AAFP
Cancers | Free Full-Text | Genome Instability in Multiple Myeloma: Facts and Factors | HTML
Myeloma kidney: the importance of assessing the response by monitoring free light chains in serum | Nefrología
Frontiers | Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma
The t(4;14) translocation and IgH-MMSET hybrid RT-PCR assays. (A)... | Download Scientific Diagram
Multiple myeloma - The Lancet
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
